Unbuckling lipodystrophy from insulin resistance and hypertension

    loading  Checking for direct PDF access through Ovid

Abstract

Lipodystrophy and insulin resistance are the core features of human PPARγ deficiency states. Metabolic complications in PPARγ deficiency, such as hypertension, have been considered to be secondary to insulin resistance. However, a new mouse model that expresses the analog of a human PPARG mutation displays minimal lipodystrophy and insulin resistance but rather severe hypertension (see the related article beginning on page 240). Furthermore, the mutant protein appears to directly modulate the renin-angiotensin system in adipose tissue, providing evidence of the pleiotropic effects of PPARγ.

Related Topics

    loading  Loading Related Articles